Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: GlaxoSmithKline
April 18, 2026
GlaxoSmithKline
Orphan Drug Designation
treatment of Vacuoles E1 enzyme, X-linked autoinflammatory, somatic (VEXAS) syndrome
Disease Area:
Rare Diseases
Source
Scroll to Top
